These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15928265)

  • 21. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for adverse drug events: a 10-year analysis.
    Evans RS; Lloyd JF; Stoddard GJ; Nebeker JR; Samore MH
    Ann Pharmacother; 2005; 39(7-8):1161-8. PubMed ID: 15897265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug events among children presenting to a hospital emergency department in Newfoundland and Labrador, Canada.
    Sikdar KC; Alaghehbandan R; Macdonald D; Barrett B; Collins KD; Gadag V
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):132-40. PubMed ID: 20033910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
    Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
    dos Santos DB; Coelho HL
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for self-reported adverse drug events among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data.
    Nebeker JR; Yarnold PR; Soltysik RC; Sauer BC; Sims SA; Samore MH; Rupper RW; Swanson KM; Savitz LA; Shinogle J; Xu W
    Med Care; 2007 Oct; 45(10 Supl 2):S81-8. PubMed ID: 17909388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventable adverse drug effects at an emergency department].
    Otero López MJ; Bajo Bajo A; Maderuelo Fernández JA; Domínguez-Gil Hurlé A
    Rev Clin Esp; 1999 Dec; 199(12):796-805. PubMed ID: 10687412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database.
    Tundia NL; Heaton PC; Kelton CM
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):866-78. PubMed ID: 21574209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
    Oderda GM; Said Q; Evans RS; Stoddard GJ; Lloyd J; Jackson K; Rublee D; Samore MH
    Ann Pharmacother; 2007 Mar; 41(3):400-6. PubMed ID: 17341537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug events in ambulatory care.
    Gandhi TK; Weingart SN; Borus J; Seger AC; Peterson J; Burdick E; Seger DL; Shu K; Federico F; Leape LL; Bates DW
    N Engl J Med; 2003 Apr; 348(16):1556-64. PubMed ID: 12700376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-rater reliability of a classification system for hospital adverse drug event reports.
    Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventable medication-related events in hospitalised children in New Zealand.
    Kunac DL; Reith DM
    N Z Med J; 2008 Apr; 121(1272):17-32. PubMed ID: 18425151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
    Cohen AL; Budnitz DS; Weidenbach KN; Jernigan DB; Schroeder TJ; Shehab N; Pollock DA
    J Pediatr; 2008 Mar; 152(3):416-21. PubMed ID: 18280852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.